Life sciences company eSense-Lab Ltd (“eSense” or the “Company”), (ASX: ESE, is pleased to announce the signing of a distribution and sales agreement with IC ACCESS (“IC”), a United Arab Emirate’s (“UAE”) entity. eSense has agreed to produce Terpenes profiles and to modify its line of products to suit the unique needs of the UAE market. In addition, the agreement provides for the potential future development of additional joint ventures between the parties for specific applications. The binding agreement signed by IC is for a period of 3 years, with a commitment by IC to purchase Terpene Strains from eSense totalling AUD$ 1,100,000 with a minimum commitment in the first year (commencing before 30 September 2018) of AUD$366,000.
ESE Price at posting:
28.5¢ Sentiment: Buy Disclosure: Held
